The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors
Open accessAbstract
The incidence of adrenocortical tumors in children from the Southern region of Brazil is higher than in other parts of the world. This fact has been related to the identification of an inherited missense mutation of the p53 (R337H) at high frequency (78-97%) in Brazilian children with adrenocortical tumors. Given the high frequency of this germline mutation in the Brazilian population, it is very likely that the R337H mutation has arisen from a common origin. In this study, we analyzed two highly polymorphic intragenic markers (VNTRp53 and p53CA) in 22 patients (16 children and 6 adults) with adrenocortical tumors carrying the germline R337H mutation and 60 normal individuals using GeneScan Fragment Analysis software. We found six and sixteen different alleles for the VNTRp53 and p53CA polymorphic markers, respectively. Two distinct alleles, both with 122 bp, were found in 56.8% (VNTRp53) and 54.5% (p53CA) of the 44 alleles from patients with adrenocortical tumors associated with the R337H mutation. Differently, these same VNTRp53 and p53CA alleles were found in 18.3% and 14.2% of 120 alleles from normal individuals, respectively (p<0.01, Chi-square test). An identical haplotype for p53 locus was also identified in 95% of the apparently unrelated Brazilian patients with adrenocortical tumors carrying the R337H mutation. In conclusion, we demonstrated a strong evidence of co-segregation between two intragenic polymorphic p53 markers and the germline R337H mutation, indicating that this mutation has originated from a single common ancestral in the great majority of the Brazilian patients with adrenocortical tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is mainly attributed to the high prevalence of the p.R337H low-penetrance allele of TP53 (6–8).”
From Adrenocortical carcinoma (2014) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Color and genomic ancestry in Brazilians
Parra, F. C., Amado, R. C., Lambertucci, J., Rocha, J., Antunes, C., & Pena, S. D. (2002) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0126614100 · Cited by 939
Incidence of malignant tumors in U.S. children
Young, J. L., & Miller, R. W. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80484-7 · Cited by 842
Ribeiro, R. C., Sandrini, F., Figueiredo, B., Zambetti, G. P., Michalkiewicz, E., Lafferty, A. R., DeLacerda, L., Rabin, M., Cadwell, C., Sampaio, G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161479898 · Cited by 541
A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer
DiGiammarino, E. L., Lee, A. S., Cadwell, C., Zhang, W., Bothner, B. B., Ribeiro, R. C., Zambetti, G. P., & Kriwacki, R. W. (2001) · Nature Structural Biology · doi:10.1038/nsb730 · Cited by 293
Latronico, A. C., Pinto, E. M., Domenice, S., Fragoso, M. C. B. V., Martin, R. M., Zerbini, M. C., Lucon, A. M., & Mendonca, B. B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7957 · Cited by 224
Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism
Jones, M. H., & Nakamura, Y. (1992) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870050113 · Cited by 207
Lack, E. E., Mulvihill, J. J., Travis, W. D., & Kozakewich, H. P. (1992) · PubMed · Cited by 65
Pinto, E. M., Billerbeck, A. E. C., Fragoso, M. C. B. V., Mendonca, B. B., & Latronico, A. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0963 · Cited by 42
Hahn, M., Fislage, R., & Pingoud, A. M. (1995) · Human Genetics · doi:10.1007/bf00208983 · Cited by 25
Cited by
Sorted by citations
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Malkin, D. M. (2011) · Genes & Cancer · doi:10.1177/1947601911413466 · Cited by 529
Adrenocortical carcinoma: a clinician’s update
Fassnacht, M., Libé, R., Kroiss, M., & Allolio, B. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.235 · Cited by 396
Achatz, M. I., Olivier, M., Calvez‐Kelm, F. L., Martel‐Planche, G., Lopes, A., Rossi, B. M., Ashton‐Prolla, P., Giugliani, R., Palmero, E. I., Vargas, F. R., et al. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.12.039 · Cited by 218
Genomic landscape of paediatric adrenocortical tumours
Pinto, E. M., Chen, X. '., Easton, J. B., Finkelstein, D., Liu, Z., Pounds, S. B., Galindo, C. R., Lund, T. C., Mardis, E. R., Wilson, R. K., et al. (2015) · Nature Communications · doi:10.1038/ncomms7302 · Cited by 212
Custódio, G., Parise, G. A., Kiesel Filho, N., Komechen, H., Sabbaga, C. C., Rosati, R., Grisa, L., Parise, I. Z. S., Pianovski, M. A. D., Fiori, C. M. C. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3711 · Cited by 201
Garritano, S., Gemignani, F., Palmero, E. I., Olivier, M., Martel-Planche, G., Le Calvez-Kelm, F., Brugiéres, L., Vargas, F. R., Brentani, R. R., Ashton-Prolla, P., et al. (2010) · Human Mutation · doi:10.1002/humu.21151 · Cited by 153
GermlineTP53Mutations and the Changing Landscape of Li-Fraumeni Syndrome
Kamihara, J., Rana, H. Q., & Garber, J. E. (2014) · Human Mutation · doi:10.1002/humu.22559 · Cited by 153
Ribeiro, R. C., Pinto, E. M., Zambetti, G. P., & Galindo, C. R. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.015 · Cited by 134
Palmero, E. I., Schüler‐Faccini, L., Caleffi, M. M., Achatz, M. I., Olivier, M., Martel‐Planche, G., Marcel, V., de Aguiar, E. S., Giacomazzi, J., Ewald, I. P., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.10.044 · Cited by 132
Genetics and epigenetics of adrenocortical tumors
Lerário, A. M., Moraitis, A. G., & Hammer, G. D. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.10.028 · Cited by 116
TP53 Germline Mutations in Adult Patients with Adrenocortical Carcinoma
Herrmann, L. J. M., Heinze, B., Fassnacht, M., Willenberg, H. S., Quinkler, M., Reisch, N., Zink, M., Allolio, B., & Hahner, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1982 · Cited by 109
Tumor Protein p53 (TP53) Testing and Li-Fraumeni Syndrome
Sorrell, A., Espenschied, C. R., Culver, J. O., & Weitzel, J. N. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0020-0 · Cited by 109
The Inherited p53 Mutation in the Brazilian PopulationPreprint
Achatz, M. I., & Zambetti, G. P. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026195 · Cited by 99
Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults
Faria, A. M., & Almeida, M. Q. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.040 · Cited by 82
TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade
Soussi, T. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-386469-7.00005-0 · Cited by 77
Picard, C., Orbach, D. H., Carton, M., Brugières, L., Renaudin, K., Aubert, S., Berrebi, D. D., Galmiche, L., Dujardin, F., Leblond, P., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0174-8 · Cited by 67
Pediatric adrenocortical tumours
Pinto, E. M., Zambetti, G. P., & Galindo, C. R. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101448 · Cited by 71
Lee, D. S., Yoon, S., Looi, L., Kang, P. C. E., Kang, I. N., Sivanandan, K., Ariffin, H., Thong, M., Chin, K. F., Taib, N. A. M., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3172 · Cited by 67
Lalli, E., & de Figueiredo, B. C. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00023 · Cited by 64
Molecular epidemiology of adrenocortical tumors in southern Brazil
Custódio, G., Komechen, H., Figueiredo, F. R. O., Fachin, N. D., Pianovski, M. A. D., & Figueiredo, B. C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.019 · Cited by 63
de Andrade, K. C., Mirabello, L. J., Stewart, D. R., Karlins, E., Koster, R., Wang, M., Gapstur, S. M., Gaudet, M. M., Freedman, N. D., Landi, M. T., et al. (2017) · Human Mutation · doi:10.1002/humu.23320 · Cited by 63
What 20 years of research has taught us about the TP53 p.R337H mutation
Pinto, E. M., & Zambetti, G. P. (2020) · Cancer · doi:10.1002/cncr.33143 · Cited by 59
XAF1 as a modifier of p53 function and cancer susceptibility
Pinto, E. M., de Figueiredo, B. C., Chen, W., Galvão, H. C. R., Formiga, M. N., Fragoso, M. C. B. V., Ashton‐Prolla, P., Ribeiro, E. M. S. F., Felix, G. T., Costa, T. E.-J. B., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba3231 · Cited by 58
Letouzé, É., Rosati, R., Komechen, H., Doghman, M., Marisa, L., Flück, C. E., de Krijger, R. R., van Noesel, M. M., Mas, J.-C., Pianovski, M. A. D., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1184 · Cited by 53
Sutter, J. A., & Grimberg, A. (2006) · PubMed · Cited by 51
TP53-Associated Pediatric Malignancies
Pinto, E. M., Ribeiro, R. C., de Figueiredo, B. C., & Zambetti, G. P. (2011) · Genes & Cancer · doi:10.1177/1947601911409745 · Cited by 49
Primary malignant tumors of the adrenal glands
Almeida, M. Q., Neto, J. E. B., Mendonca, B. B., Latronico, A. C., & Fragoso, M. C. B. V. (2018) · Clinics · doi:10.6061/clinics/2018/e756s · Cited by 46
Frequency of the TP53 R337H variant in sporadic breast cancer and its impact on genomic instability
Mathias, C., Bortoletto, S., Centa, A., Komechen, H., de Lima, R. S., Fonseca, A. S., Sebastião, A. P. M., Urban, C. A., Soares, E. W. S., Prando, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73282-y · Cited by 44
Adrenocortical Carcinoma in Childhood: A Systematic Review
Riedmeier, M., Decarolis, B., Haubitz, I., Müller, S., Uttinger, K., Boerner, K., Reibetanz, J., Wiegering, A., Härtel, C., Schlegel, P., et al. (2021) · Cancers · doi:10.3390/cancers13215266 · Cited by 48
Prevalence and impact of founder mutations in hereditary breast cancer in Latin America
Ashton‐Prolla, P., & Vargas, F. R. (2014) · Genetics and Molecular Biology · doi:10.1590/s1415-47572014000200009 · Cited by 42
Pinto, E. M., Billerbeck, A. E. C., Fragoso, M. C. B. V., Mendonca, B. B., & Latronico, A. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0963 · Cited by 42
Ferreira, A. M., Balderrama-Brondani, V., Helena, V. P., Charchar, H. L. S., Zerbini, M. C. N., Leite, L. A. S., Hoff, A. O., Latronico, A. C., Mendonca, B. B., Estevez-Diz, M. D. P., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.04.011 · Cited by 36
Pediatric adrenocortical tumor – review and management update
Balderrama-Brondani, V., & Fragoso, M. C. B. V. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000540 · Cited by 35
Jouinot, A., & Bertherat, J. Y. (2019) · Experientia supplementum · doi:10.1007/978-3-030-25905-1_9 · Cited by 32
Adrenocortical carcinoma: a literature review
Thampi, A., Shah, E., Elshimy, G., & Correa, R. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.12.28 · Cited by 32
Advances in translational research of the rare cancer type adrenocortical carcinoma
Ghosh, C., Hu, J., & Kebebew, E. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00623-0 · Cited by 34
Costa, T. E. J. B., Gerber, V. K. Q., Ibañez, H. C., Melanda, V. S., Parise, I. Z. S., Watanabe, F. M., Pianovski, M. A. D., Fiori, C. M. C. M., Fabro, A. L. M. R., Silva, D. B., et al. (2019) · Cancers · doi:10.3390/cancers11111804 · Cited by 32
The human adrenal cortex: growth control and disorders
Lotfi, C. F. P., Kremer, J. L., Passaia, B. D. S., & Cavalcante, I. P. (2018) · Clinics · doi:10.6061/clinics/2018/e473s · Cited by 31
A Rare TP53 Mutation Predominant in Ashkenazi Jews Confers Risk of Multiple Cancers
Powers, J. M., Pinto, E. M., Barnoud, T., Leung, J. C., Martynyuk, T., Kossenkov, A. V., Philips, A. H., Desai, H., Hausler, R. M., Kelly, G., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1390 · Cited by 31
Giacomazzi, J., Selistre, S. G. D. A., Duarte, J. Á., Ribeiro, J. P., Vieira, P. J., Macedo, G. D. S., Rossi, C., Czepielewski, M. A., Netto, C. B. O., Hainaut, P. L., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-187 · Cited by 30
Chukkalore, D., MacDougall, K. N., Master, V. A., Bilen, M. A., & Nazha, B. (2024) · The Oncologist · doi:10.1093/oncolo/oyae029 · Cited by 29
Lerário, A. M., Mohan, D. R., Montenegro, L. R., Funari, M. F. A., Nishi, M. Y., Narcizo, A. D. M., Benedetti, A. F. F., Oba‐Shinjo, S. M., Vitorino, A. J., Santos, R. A. S. X. D., et al. (2020) · Clinics · doi:10.6061/clinics/2020/e1913 · Cited by 27
Molecular pathology of adrenal cortical tumors: Separating adenomas from carcinomas
Giordano, T. J. (2006) · Endocrine Pathology · doi:10.1007/s12022-006-0007-z · Cited by 27
de Andrade, K. C., Santiago, K. M., Fortes, F. P., Mambelli, L. I., de Nóbrega, A. F., & Achatz, M. I. (2016) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2014-0343 · Cited by 26
Adrenocortical carcinoma in patients with MEN1: a kindred report and review of the literature
Wang, W., Han, R., Ye, L., Xie, J., Tao, B., Sun, F., Zhuo, R., Chen, X., Deng, X., Ye, C., et al. (2019) · Endocrine Connections · doi:10.1530/ec-18-0526 · Cited by 29
Jeffers, J. R., Pinto, E. M., Rehg, J. E., Clay, M. R., Wang, J., Neale, G. A. M., Heath, R. J., Lozano, G., Lalli, E., de Figueiredo, B. C., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1750 · Cited by 22
Choe, J. H., Kawase, T., Xu, A., Guzman, A., Obradović, A., Low-Calle, A. M., Alaghebandan, B., Raghavan, A., Long, K., Hwang, P. M., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0882 · Cited by 25
Altered expression of noncanonical Wnt pathway genes in paediatric and adult adrenocortical tumours
Mermejo, L. M., Leal, L. F., Colli, L. M., Fragoso, M. C. B. V., Latronico, A. C., Tone, L. G., Scrideli, C. A., Tucci, S., Martinelli, C. E., Yunes, J. A., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12462 · Cited by 24
Else, T., & Galindo, C. R. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0244-z · Cited by 24
Furuya, T. K., Jacob, C. E., Tomitão, M. T. P., Camacho, L. C. C., Ramos, M. F. K. P., Eluf‐Neto, J., Alves, V. A. F., Zilberstein, B., Cecconello, I., Ribeiro, U., et al. (2018) · Genes · doi:10.3390/genes9120631 · Cited by 24
Pathological and Genetic Stratification for Management of Adrenocortical Carcinoma
Clay, M. R., Pinto, E. M., Fishbein, L. M., Else, T., & Kiseljak‐Vassiliades, K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab866 · Cited by 24
Pinto, E. M., Faucz, F. R., Paza, L. Z., Wu, G., Fernandes, E. S., Bertherat, J. Y., Stratakis, C. A., Lalli, E., Ribeiro, R. C., Galindo, C. R., et al. (2020) · Cancers · doi:10.3390/cancers12020506 · Cited by 22
Childhood Adrenocortical Tumours: a Review
Pereira, R. M., DeLacerda, L., Lacerda, H. M., Michalkiewicz, E., Sandrini, F., & Sandrini, R. (2006) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-4-2-81 · Cited by 22
Choong, S. S., Latiff, Z. A., Mohamed, M. B., Lim, L. L., Chen, K., Vengidasan, L., Razali, H., Rahman, E. A., Ariffin, H., & for Malaysian Society of Paediatric Haematology‐Oncology (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01841.x · Cited by 22
Emerging insights into ethnic-specific TP53 germline variants
Fischer, N. W., Ma, Y.-H. V., & Gariépy, J. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad106 · Cited by 24
Borges, L. M., & Ayres, F. M. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.16.4 · Cited by 19
Palmero, E. I., Caleffi, M. M., Schüler‐Faccini, L., Roth, F. L., Kalakun, L., Netto, C. B. O., Skonieski, G., Giacomazzi, J., Weber, B., Giugliani, R., et al. (2009) · Genetics and Molecular Biology · doi:10.1590/s1415-47572009005000058 · Cited by 18
A differential diagnosis of inherited endocrine tumors and their tumor counterparts
Toledo, S. P. A., Lourenço, D. M., & Toledo, R. A. (2013) · Clinics · doi:10.6061/clinics/2013(07)24 · Cited by 16
Cavagna, R. D. O., Pinto, I. A., de Paula, F. E., Berardinelli, G. N., Sant'Anna, D., Santana, I. V. V., da Silva, V. D., da Silva, E. C. A., Miziara, J. E., Dias, J. M., et al. (2022) · Brazilian Journal of Oncology · doi:10.1055/s-0044-1795525 · Cited by 15
Fujisawa, Y., Sakaguchi, K., Ono, H., Yamaguchi, R., Kato, F., Kagami, M., Fukami, M., & Ogata, T. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.031 · Cited by 16
Schwartz, A., Cahill, S. R., Stokes, S. M., Castillo, D., Tung, N., Weitzel, J. N., Rana, H. Q., & Garber, J. E. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00278 · Cited by 18
TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset
Pinto, C., Veiga, I., Pinheiro, M., Peixoto, A., Pinto, A., Lopes, J. M., Reis, R. M., Oliveíra, C., Baptista, M., Roque, L., et al. (2009) · Familial Cancer · doi:10.1007/s10689-009-9251-y · Cited by 16
Personalized Care of Patients with Adrenocortical Carcinoma: A Comprehensive Approach
Miller, B. S., & Else, T. (2017) · Endocrine Practice · doi:10.4158/ep161719.ra · Cited by 15
Riedmeier, M., Decarolis, B., Haubitz, I., Reibetanz, J., Wiegering, A., Härtel, C., Schlegel, P., Faßnacht, M., & Wiegering, V. A. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0173 · Cited by 15
Surakhy, M., Wallace, M. D., Bond, E. E., Grochola, L. F., Perez, H., Giovannantonio, M. D., Zhang, P., Malkin, D. M., Carter, H. K., Parise, I. Z. S., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0764-3 · Cited by 15
Mastellaro, M. J., Ribeiro, R. C., de Oliveira-Filho, A. G., Seidinger, A. L., Cardinalli, I. A., MIRANDA, E. C. M., Aguiar, S. S., Brandalise, S. R., Yunes, J. A., & Filho, A. A. B. (2017) · Jornal de Pediatria · doi:10.1016/j.jped.2017.06.009 · Cited by 14
Management of Adrenal Tumors in Pediatric Patients
Abib, S. D. C. V., & Weldon, C. B. (2021) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2020.11.012 · Cited by 14
Molecular markers and targeted therapies for adrenocortical carcinoma
Xu, Y., Qi, Y., Zhu, Y., Ning, G., & Huang, Y. (2013) · Clinical Endocrinology · doi:10.1111/cen.12358 · Cited by 13
TP53 p.Arg337His geographic distribution correlates with adrenocortical tumor occurrence
Seidinger, A. L., Caminha, I. P., Mastellaro, M. J., Gabetta, C. S., Nowill, A. E., Pinheiro, V. R. P., & Yunes, J. A. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1168 · Cited by 13
Benign SNPs in the Coding Region of TP53 : Finding the Needles in a Haystack of Pathogenic Variants
Soussi, T. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0172 · Cited by 13
Number of rare germline CNVs and TP53 mutation types
Silva, A. G., Achatz, M. I., Krepischi, A. C. V., Pearson, P. L., & Rosenberg, C. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-101 · Cited by 12
65 YEARS OF THE DOUBLE HELIX: Endocrine tumour syndromes in children and adolescents
Goudie, C., Hannah‐Shmouni, F., Kavak, M., Stratakis, C. A., & Foulkes, W. D. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0160 · Cited by 12
Balderrama-Brondani, V., Montenegro, L. R., Lacombe, A. M. F., Magalhães, B. M., Nishi, M. Y., Funari, M. F. A., Narcizo, A. D. M., Cardoso, L. C., Siqueira, S. A. C., Zerbini, M. C. N., et al. (2020) · Cancers · doi:10.3390/cancers12030621 · Cited by 11
Ru, W., Yang, M., Xu, S., Li, M.-J., & Tang, D. (2017) · Pediatric Surgery International · doi:10.1007/s00383-017-4073-8 · Cited by 11
Haplotype-resolved germline and somatic alterations in renal medullary carcinomas
Tan, K. T., Kim, H., Carrot‐Zhang, J., Zhang, Y., Kim, W. J., Kugener, G., Wala, J. A., Howard, T. P., Chi, Y.-Y., Beroukhim, R., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00929-4 · Cited by 12
Frone, M. N., Stewart, D. R., Savage, S. A., & Khincha, P. P. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00320 · Cited by 10
Correlation between selected angiogenic markers and prognosis in pediatric adrenocortical tumors
Dias, A. I. B. D. S., Fachin, C. G., de Avó, L. R. D. S., Frazão, C. V. G., Caran, E. M. M., Schettini, S., Alves, M. T. D. S., Ribeiro, R. C., & Abib, S. D. C. V. (2014) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2014.12.006 · Cited by 9
Identity by Descent Mapping of Founder Mutations in Cancer Using High-Resolution Tumor SNP Data
Letouzé, É., Sow, A., Petel, F. X., Rosati, R., de Figueiredo, B. C., Burnichon, N., Gimenez‐Roqueplo, A., Lalli, E., & de Reyniès, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035897 · Cited by 9
Pinheiro, C. M., Granja, S., Longatto‐Filho, A., Faria, A. M., Fragoso, M. C. B. V., Lovisolo, S. M., Bonatelli, M., Costa, R. F. A., Lerário, A. M., Almeida, M. Q., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19135 · Cited by 9
Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility
Pinto, E. M., Fridman, C., de Figueiredo, B. C., Salvador, H., Teixeira, M. R., Pinto, C., Pinheiro, M., Kratz, C. P., Lavarino, C. E., Legal, E. F.-D., et al. (2023) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2023.100244 · Cited by 8
O'Neill, A. F., Ribeiro, R. C., Pinto, E. M., Clay, M. R., Zambetti, G. P., Orr, B. A., Weldon, C. B., & Galindo, C. R. (2024) · Cancer Management and Research · doi:10.2147/cmar.s348725 · Cited by 10
Radiotherapy for pediatric adrenocortical carcinoma – Review of the literature
Wiegering, V. A., Riedmeier, M., Thompson, L. D. �., Virgone, C., Redlich, A., Kuhlen, M., Gültekin, M., Yalçın, B., Decarolis, B., Härtel, C., et al. (2022) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2022.05.003 · Cited by 9
Costa, M. H. S., Latronico, A. C., Martin, R. M., Barbosa, A. S., Almeida, M. Q., Lotfi, C. F. P., Valassi, H. P. L., Nishi, M. Y., Lucón, A. M., Siqueira, S. A. C., et al. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0395 · Cited by 7
Adrenal Tumors in Children and Adolescents in Sweden: A Register-Based Study Covering 15 Years
Terezaki, E., Calissendorff, J., Mannheimer, B., Lindh, J. D., & Falhammar, H. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf058 · Cited by 6
Structural Basis of Mutation-Dependent p53 Tetramerization Deficiency
Rigoli, M., Spagnolli, G., Lorengo, G., Monti, P., Potestio, R., Biasini, E., & Inga, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147960 · Cited by 6
Moszczyńska, E., Baszyńska–Wilk, M., Tutka, A., Bogusz-Wójcik, A., Dasiewicz, P., Gryniewicz–Kwiatkowska, O., Walewska‐Wolf, M., Stepaniuk, M., Majak, D., & Grajkowska, W. (2024) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.5114/pedm.2023.133315 · Cited by 6
Tumores adrenocorticais na criança: da abordagem clínica à avaliação molecular
Antonini, S. R. R., Colli, L. M., Ferro, L., Mermejo, L. M., & de Castro, M. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000800014 · Cited by 6
Fischer, N. W., Ong, N., Laverty, B., Psarianos, P., Giovino, C., Alon, N., Montellier, E., Hainaut, P. L., Maxwell, K. N., Kratz, C. P., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63528-6 · Cited by 9
Spectrum of germline pathogenic variants in Brazilian hereditary breast/ovarian cancer cases
de Faria, J. P. G., Assumpção, J. G., Matos, L. D. O., Soardi, F. C., Bretz, G. P. M., Friedman, E., & Marco, L. A. D. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07383-x · Cited by 5
The molecular genetics of adrenal cushing
Vaduva, P., & Bertherat, J. Y. (2024) · HORMONES · doi:10.1007/s42000-024-00608-0 · Cited by 5
How Do Cancer-Related Mutations Affect the Oligomerisation State of the p53 Tetramerisation Domain?
Nicolini, F., Todorovski, T., Puig, E., Díaz‐Lobo, M., Vilaseca, M., García, J., Andreu, D., & Giralt, E. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45060317 · Cited by 5
da Silva, K. R., Veronez, L. C., Corrêa, C. A. P., Lira, R. C. P., Baroni, M., Queiróz, R. G. D. P., Antonini, S. R. R., Yunes, J. A., Brandalise, S. R., Tone, L. G., et al. (2022) · Human Cell · doi:10.1007/s13577-022-00778-2 · Cited by 5
Wang, W., Chang, G., Sun, Y., Zhuo, R., Li, H., Hu, Y., & Ye, C. (2021) · Journal of Investigative Surgery · doi:10.1080/08941939.2021.1968981 · Cited by 5
Pinto, E. M., Ribeiro, R. C., Li, J., Taja‐Chayeb, L., Carrasco, L. F., Peña-Torres, M. D. L., Vidal-Millán, S., Maldonado-Mtz, H., Dueñas‐González, A., McGregor, L. M., et al. (2012) · Oncogenesis · doi:10.1038/oncsis.2012.1 · Cited by 5
Legal, E. F.-D., Ascurra, M., Custódio, G., Legal-Ayala, H., Monteiro, M. M., Vega, C., Fernández-Nestosa, M. J., Vega, S., Sade, E. R., Coelho, I. M. M., et al. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.01.005 · Cited by 5
da Silva, P. F. F., Goveia, R. M., Teixeira, T. B., Gamba, B. F., de Lima, A. P., Rogatto, S. R., & Silveira-Lacerda, E. D. P. (2022) · Biomolecules · doi:10.3390/biom12050640 · Cited by 4
Vieira, I. A., Pezzi, E. H., Bandeira, I. C., Reis, L. B., Rocha, Y. M. D. A., Fernandes, B., Siebert, M., Miyamoto, K. N., Siqueira, M., Achatz, M. I., et al. (2023) · Gene · doi:10.1016/j.gene.2023.148069 · Cited by 4
Lerário, A. M., Mendonca, B. B., & Lin, C. J. (2005) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302005000500016 · Cited by 4
Inflammation-based score in pediatric adrenocortical carcinoma
Riedmeier, M., Idkowiak, J., Frey, H., Antonini, S. R. R., Canali, G. F. L., Classen, C. F., Domínguez‐Pinilla, N., Faßnacht, M., Fuchs, S., Härtel, C., et al. (2025) · Endocrine Related Cancer · doi:10.1530/erc-24-0244 · Cited by 3
Metadata
- Authors
- Pinto, E. M., Billerbeck, A. E. C., Villares, M. C. B. F., Domenice, S., Mendonça, B. B., & Latronico, A. C.
- Affiliations
- Universidade de São Paulo (BR)
- Universidade de São Paulo, Brasil
- Venue
- Arquivos Brasileiros de Endocrinologia & Metabologia
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2004-10
- Volume
- 48
- Issue
- 5
- Pages
- 647-650
- ISSN
- 0004-2730 (ISSN-L)
- OpenAlex
- W2090940786
- Cited by
- 153
- References
- 9
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 10 · 2023: 9 · 2022: 11 · 2021: 11 · 2020: 15 · 2019: 4 · 2018: 6 · 2017: 6 · 2016: 3 · 2015: 6 · 2014: 5 · 2013: 10 · 2012: 9
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- Arquivos Brasileiros de Endocrinologia & Metabologia (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- founder effect, germline mutations, adrenocortical tumors, congenital adrenal hyperplasia, mutation origin, Brazilian patients
- MeSH terms
- Adolescent, Adrenal Cortex Neoplasms, Adult, Alleles, Brazil, Child, Child, Preschool, Humans, Infant, Middle Aged, Mutation, Genes, p53
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
